Enanta Pharmaceuticals In... (ENTA)
4.93
0.09 (1.86%)
At close: Jan 15, 2025, 12:41 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -116.05M | -133.82M | -121.75M | -79.00M | -36.17M | 46.38M | 71.96M | 17.71M | 21.67M | 78.99M | 34.44M | 9.63M | 21.40M | 23.31M | 7.90M |
| Depreciation & Amortization | 2.34M | 2.37M | 2.97M | 3.33M | 3.64M | 3.26M | 2.52M | 2.14M | 1.66M | 639.00K | 352.00K | 221.00K | 172.00K | 499.00K | 553.00K |
| Stock-Based Compensation | 26.80M | 28.22M | 26.97M | 20.99M | 19.57M | 19.23M | 15.85M | 13.07M | 9.35M | 5.84M | 2.68M | 1.06M | 424.00K | 225.00K | 259.00K |
| Other Working Capital | 6.57M | -243.00K | 8.16M | -17.38M | 2.26M | 291.00K | -92.00K | 478.00K | 397.00K | 649.00K | -10.00K | 15.00K | 22.00K | -814.00K | -20.14M |
| Other Non-Cash Items | 1.02M | 2.60M | 242.00K | -1.98M | -3.47M | -5.80M | -1.17M | -581.00K | -749.00K | -2.99M | 176.00K | -1.78M | 535.00K | 2.75M | -480.00K |
| Deferred Income Tax | n/a | -10.55M | n/a | 345.00K | 10.61M | -3.14M | 1.86M | -1.65M | -2.29M | 11.03M | -15.21M | 781.00K | n/a | -360.00K | n/a |
| Change in Working Capital | 7.13M | 8.02M | 6.79M | -13.69M | 12.90M | 11.49M | -61.79M | 21.97M | 6.17M | -16.83M | -2.26M | 741.00K | 93.00K | -2.40M | -18.41M |
| Operating Cash Flow | -78.76M | -103.15M | -84.78M | -70.00M | 7.09M | 71.42M | 29.22M | 52.65M | 35.81M | 76.67M | 20.18M | 10.65M | 22.62M | 24.02M | -10.18M |
| Capital Expenditures | -17.95M | -9.06M | -2.13M | -750.00K | -1.45M | -5.42M | -2.98M | -2.51M | -4.74M | -2.34M | -1.03M | -606.00K | -252.00K | -445.00K | -37.00K |
| Acquisitions | n/a | 44.52M | -54.90M | -37.74M | -21.27M | 86.66M | n/a | n/a | n/a | 9.00K | n/a | n/a | 66.00K | 9.00K | n/a |
| Purchase of Investments | -307.28M | -373.39M | -171.45M | -307.35M | -338.55M | -549.31M | -293.10M | -251.37M | -192.43M | -196.30M | -98.41M | -115.89M | -47.69M | -33.57M | -603.00K |
| Sales Maturities Of Investments | 383.46M | 328.87M | 228.47M | 345.09M | 359.83M | 468.06M | 260.68M | 249.31M | 153.50M | 110.62M | 99.93M | 47.28M | 28.70M | 16.76M | 2.30M |
| Other Investing Acitivies | n/a | -44.52M | 54.90M | 37.74M | 21.27M | -86.66M | -32.42M | -2.07M | -38.92M | -172.00K | 3.00K | -68.61M | 1.14M | -436.00K | n/a |
| Investing Cash Flow | 58.23M | -53.58M | 54.90M | 36.99M | 19.83M | -86.66M | -35.40M | -4.57M | -43.66M | -88.19M | 497.00K | -69.22M | -18.04M | -17.68M | 1.66M |
| Debt Repayment | -27.48M | n/a | n/a | n/a | n/a | -86.00K | -79.00K | -73.00K | -68.00K | n/a | n/a | n/a | n/a | n/a | -7.00K |
| Common Stock Repurchased | n/a | n/a | -1.23M | -534.00K | -1.50M | -4.19M | -1.76M | -202.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -147.00K | 198.13M | 20.03M | 3.08M | 8.98M | 2.66M | 4.49M | 1.09M | 2.77M | 2.54M | 1.16M | -2.98M | -909.00K | 34.00K | 15.00K |
| Financial Cash Flow | -27.63M | 198.13M | 20.03M | 3.08M | 8.98M | 2.57M | 4.41M | 1.02M | 2.71M | 2.54M | 1.16M | 56.91M | -909.00K | 34.00K | 8.00K |
| Net Cash Flow | -48.16M | 41.39M | -9.85M | -29.93M | 35.90M | -12.67M | -1.77M | 49.10M | -5.15M | -8.97M | 21.84M | -1.65M | 3.67M | 6.37M | -8.50M |
| Free Cash Flow | -96.71M | -112.21M | -86.91M | -70.75M | 5.64M | 66.00M | 26.24M | 50.15M | 31.07M | 74.34M | 19.15M | 10.05M | 22.37M | 23.57M | -10.21M |